2022-04-22
Elixir Clinical Research completed A round financing worth of $52 million, which is jointly invested by LYFE Capital, Sinovation Ventures and Chow Tai Fook
In recent years, China's life science industry has been developing rapidly, and the CRO industry has received a lot of attention from all walks of life. Compared with traditional CRO operation model, Elixir Clinical Research
Details